Clinical trial
Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
NCT03105310 is registered in ClinicalTrials.gov with Aga Khan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
- Lead sponsor
- Aga Khan University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- June 30, 2017
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.